Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2025

Feb 7, 2025

30718_dirs_2025-02-07_330cae5a-c0df-4e74-aa71-e524de7d95ae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-02-01

Reporting Person: Herr Amy E. (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1860 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $44.33 2025-08-08 Common Stock (3256) Indirect
Stock Option (Right to Buy) $47.60 2026-08-07 Common Stock (6636) Indirect
Stock Option (Right to Buy) $66.97 2027-08-05 Common Stock (4472) Indirect
Stock Option (Right to Buy) $120.46 2028-08-06 Common Stock (2076) Indirect
Stock Option (Right to Buy) $94.52 2029-08-15 Common Stock (2104) Indirect
Stock Option (Right to Buy) $84.61 2030-08-15 Common Stock (1084) Indirect
Stock Option (Right to Buy) $74.91 2034-08-15 Common Stock (1468) Indirect
Restricted Stock Units $ Common Stock (237) Indirect
Restricted Stock Units $ Common Stock (480) Indirect

Footnotes

F1: Fully vested.

F2: 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.

F3: 528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.

F4: 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.

F5: 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

F6: 119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.

F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F8: 160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.